市場調查報告書

PoC (照護現場) 診斷藥的全球市場:未來展望

Global Point-of-Care Diagnostics Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 869644
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
PoC (照護現場) 診斷藥的全球市場:未來展望 Global Point-of-Care Diagnostics Market 2019-2025
出版日期: 2019年06月10日內容資訊: 英文
簡介

本報告提供全球PoC (照護現場) 診斷的市場現況與展望相關分析,提供系統概要和市場基本結構,來自外部的宏觀·微觀影響,主要的促進·阻礙因素,全球整體及地區別的市場趨勢預測 (今後7年份),各市場區隔 (各用途,不同處方形態,各終端用戶)的詳細趨勢,最新的市場競爭情形,主要企業簡介等調查。

第1章 分析概要

第2章 市場概要與考察

  • 市場範圍
  • 分析師的見解與目前市場趨勢
    • 分析的要點
    • 建議
    • 結論
  • 世界各國的法規·規定

第3章 競爭環境

  • 企業一覽
  • 主要策略分析
  • 主要企業分析
    • Abbott Laboratories, Inc.
      • 概要
      • 財務分析
      • SWOT分析
      • 近幾年趨勢
    • F. Hoffmann-La Roche, Ltd.
    • Danaher Corp.
    • EKF Diagnostics Holdings PLC
    • Siemens Healthcare GmbH

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 全球PoC診斷藥市場:各用途
    • 心臟疾病
    • 糖尿病
    • 感染疾病
    • 腫瘤
    • 其他 (血液檢驗,妊娠檢驗)
  • 全球PoC診斷藥市場:不同處方形態
    • 成藥
    • 處方藥
  • 全球PoC診斷藥市場:各終端用戶
    • 醫院·診療所
    • 家庭治療
    • 其他 (門診病人治療)

第6章 各地區分析

  • 北美 (美國,加拿大)
  • 歐洲 (英國,德國,義大利,西班牙,法國等)
  • 亞太地區 (中國,印度,日本等)
  • 其他的國家 (RoW)

第7章 企業簡介

  • Abbott Laboratories, Inc.
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson, and Co.
  • Biomeme, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostics Systems, Inc.
  • Danaher Corp.
  • DNAe Group Holdings, Ltd.
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche, Ltd.
  • Instrumentation Laboratory SpA
  • Nova Biomedical Corp.
  • Qiagen N.V.
  • Quidel Corp.
  • Sekisui Diagnostics LLC
  • Siemens Healthcare GmbH
  • Sinocare, Inc.
  • Sysmex
  • Trinity Biotech PLC
目錄
Product Code: OMR2019700

Global Point-of-Care Diagnostics Market Size, Share & Trends Analysis Report by Application (Cardiology, Diabetes, Infectious Diseases, Oncology and Other Applications), by Prescription Mode (Over-The-Counter Testing and Prescription-Based Diagnostics), by End-User (Hospital and Clinics, Home Care, and Other), and Forecast, 2019-2025

The point-of-care diagnostics are medical devices used for early diagnosis & monitoring of various diseases such as cancer, diabetes, infectious diseases, and others. There is a high growth opportunity in this market due to the increase in investment by public foundations and new products development. However, the high cost of the device and its installation along with product recall due to technical failure are some of the restraint to the point-of-care diagnostics market.

The global point-of-care diagnostics market is segmented on the basis of application, prescription mode and end user. On the basis of the application, it is further classified into cardiology, diabetes, infectious diseases, oncology and other applications. The infectious disease segment is expected to show a significant growth owing to the increase in the number of affected patients and increasing awareness about infectious disease testing point-of-care devices. On the basis of the prescription mode, the market is classified into the over-the-counter testing and prescription-based diagnostics. Among these, the prescription-based diagnostics segment are expected to show significant growth attributed to lack of awareness on over-the-counter testing devices.

The global point-of-care diagnostics market is further analyzed and segmented on the basis of regions into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to have considerable market in terms of market share in the global point-of-care diagnostics market. This is mainly attributed to the high prevalence of diseases, development of healthcare infrastructure and mostly due to the presence of major players such as Abbott Laboratories and Danaher Corp. Asia-Pacific is growing due to increasing quality of the healthcare system and increasing awareness among people in emerging countries, such as India, are the reason for the high market growth.

Key market players operating in the global point-of-care diagnostics market include F. Hoffmann-La Roche Ltd., Danaher Corp., Abbott Laboratories, Inc., bioMerieux SA, and Siemens Healthcare GmbH among others. These companies adopt various strategies such as partnership & collaborations, finding a new market or Product innovations in their core competency in order to stay competitive in the market. For instance, In April 2017, Chembio Diagnostics, Inc., collaborated with FIND to develop Hepatitis-C virus detecting point-of-care device.

Research Methodology

The market study of the global point-of-care diagnostics market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behaviour and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue.

The report is intended for healthcare companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  • 1. Global Point-of-care diagnostics Market Research and Analysis by Application
  • 2. Global Point-of-care diagnostics Market Research and Analysis by Prescription Mode
  • 3. Global Point-of-care diagnostics Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global point-of-care diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global point-of-care diagnostics market.
  • Insights about market determinants which are stimulating the global point-of-care diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Study
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Abbott Laboratories, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. F. Hoffmann-La Roche, Ltd.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Danaher Corp.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. EKF Diagnostics Holdings PLC
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Siemens Healthcare GmbH
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Point-of-care Diagnostic Market by Application

5.1.1 Cardiology

5.1.2 Diabetes

5.1.4 Infectious Diseases

5.1.4 Oncology

5.1.5 Other Applications (Haematology Testing, Pregnancy Testing)

  • 5.2. Global Point-of-care Diagnostic Market by Prescription Mode
    • 5.2.1. Over-The-Counter Testing
    • 5.2.2. Prescription-Based Diagnostics
  • 5.3. Global Point-of-care Diagnostic Market by End-User
    • 5.3.1. Hospitals and Clinics
    • 5.3.2. Home Care
    • 5.3.3. Other (Ambulatory Care)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. The US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. AccuBioTech Co., Ltd.
  • 7.3. Becton, Dickinson, and Co.
  • 7.4. Biomeme, Inc.
  • 7.5. bioMerieux SA
  • 7.6. Bio-Rad Laboratories, Inc.
  • 7.7. Chembio Diagnostics Systems, Inc.
  • 7.8. Danaher Corp.
  • 7.9. DNAe Group Holdings, Ltd.
  • 7.10. EKF Diagnostics Holdings PLC
  • 7.11. F. Hoffmann-La Roche, Ltd.
  • 7.12. Instrumentation Laboratory SpA
  • 7.13. Nova Biomedical Corp.
  • 7.14. Qiagen N.V.
  • 7.15. Quidel Corp.
  • 7.16. Sekisui Diagnostics LLC
  • 7.17. Siemens Healthcare GmbH
  • 7.18. Sinocare, Inc.
  • 7.19. Sysmex Corp.
  • 7.20. Trinity Biotech PLC

List of Tables

  • 1. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 2. GLOBAL CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 3. GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 4. GLOBAL INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 5. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 6. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 7. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
  • 8. GLOBAL OVER-THE-COUNTER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 9. GLOBAL PRESCRIPTION-BASED DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 10. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
  • 11. GLOBAL HOSPITAL AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 12. GLOBAL HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 13. GLOBAL LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 14. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 15. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025($ MILLION)
  • 16. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025($ MILLION)
  • 17. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 18. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
  • 19. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
  • 20. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025($ MILLION)
  • 21. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 22. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
  • 23. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
  • 24. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025($ MILLION)
  • 25. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 26. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE 2018-2025($ MILLION)
  • 27. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
  • 28. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 29. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
  • 30. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)

List of Figures

  • 1. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET SHARE BY APPLICATION, 2018 VS 2025(%)
  • 2. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET SHARE BY PRESCRIPTION MODE, 2018 VS 2025(%)
  • 3. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET SHARE BY END USER, 2018 VS 2025(%)
  • 4. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET SHARE BY GEOGRAPHY, 2018 VS 2025(%)
  • 5. US POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 6. CANADA POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 7. UK POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 8. FRANCE POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 9. GERMANY POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 10. ITALY POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 11. SPAIN POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 12. ROE POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 13. INDIA POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 14. CHINA POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 15. JAPAN POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 16. REST OF ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 17. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)